Marty Makary Criticized FDA, Named Trump's Pick for Commissioner Amid Major Health Appointments
Marty Makary, a renowned pancreatic surgeon from Johns Hopkins University, has been nominated by President-elect Donald Trump to lead the Food and Drug Administration (FDA). This appointment stands out as Makary has been a vocal critic of the FDA and CDC's handling of decision-making during the COVID-19 pandemic while identifying as "pro-vaccine." His views diverged from mainstream opinions, especially regarding the necessity and frequency of vaccinations during the pandemic[1][2]. As the newly appointed FDA head, Makary will oversee an agency of 18,000 employees, with the responsibility of evaluating new drugs and devices, as well as monitoring food safety[1]. His appointment highlights Trump's agenda to reform federal agencies and challenge existing practices, a task that Makary is expected to navigate carefully, given his role in restoring public trust in the FDA[2][3].
References
- Johns Hopkins surgeon Makary is Trump’s pick to lead FDA
- Johns Hopkins surgeon Makary is Trump’s pick to lead FDA
- Trump selects surgeon and author Martin Makary for FDA commissioner post
- Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for top FDA job: reports
- COVID-19 Critic Marty Makary Is Trump’s Likely Pick for FDA Top Post
Explore Further
What specific changes does Marty Makary plan to implement at the FDA to address his critiques of the agency's COVID-19 policies?
How might Makary's pro-vaccine stance yet criticism of certain mandates impact the FDA's future vaccine policy?
What challenges might Marty Makary face in restoring public trust in the FDA?
How does Makary's traditional medical background contrast with other controversial picks by Trump for health-related roles?
What are the potential implications of Marty Makary's leadership for new drug evaluations and food safety standards at the FDA?